Real-time enrollment status for this symptomatic venous thromboembolism (vte) clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:09 PM UTC
| NCT Number | NCT07213778 |
| Recruiting Status | Recruiting |
| Condition | Symptomatic Venous Thromboembolism (VTE) |
| Phase | PHASE3 |
| Target Enrollment | 2,000 participants |
| Active Locations | 36 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | October 8, 2026 (1 week ago) |
As of October 21, 2026: Clinical trial NCT07213778 is currently recruiting participants. This phase3 study for symptomatic venous thromboembolism (vte) is actively seeking new participants at 36 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07213778 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 36 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07213778 was last updated 1 week ago (October 8, 2026). HelloStudys verifies this status automatically.